Published on 12 May 2024 on Simply Wall St. via Yahoo Finance
Arcus Biosciences, Inc. (NYSE:RCUS) Reported Earnings Last Week And Analysts Are Already Upgrading...
Arcus Biosciences, Inc. (NYSE:RCUS) investors will be delighted, with the company turning in some strong numbers with its latest results. The results were impressive, with revenues of US$145m exceeding analyst forecasts by 404%, and statutory losses of US$0.05 were likewise much smaller than the analysts had forecast. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
View our latest analysis for Arcus Biosciences
